drugset / Trial / NCT00381030

Effects of Carvedilol on Health Outcomes in Heart Failure

NCT00381030

Phase 4 Completed 100 enrolled Denver Health and Hospital Authority
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of our study was to determine if a strategy of starting a heart medication (Beta-blocker) before patients leave the hospital and then being seen by a nurse manager would reduce subsequent hospitalizations compared to usual care. Hypothesis: A nurse-directed heart failure management program with inpatient initiation of beta blockers will improve health outcomes in a vulnerable, predominantly Hispanic and African American population.

Timeline

Start
2002-10
Primary completion
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified